Project Profile

TCD With Transfusions Changing to Hydroxyurea (TWiTCH): A Phase III randomized clinical trial to compare standard therapy (erythrocyte transfusions) to alternative therapy (hydroxyurea) for the prevention of primary stroke in pediatric subjects with sickl

Keyword Search